0709 203000 - Nairobi 0709 983000 - Kilifi
0709 203000 - NRB 0709 983000 - Kilifi
0709 203000 - NRB | 0709 983000 - Kilifi

Back Home

Philip Bejon/Front Immunol


14 results

B and T cell responses to pre-erythrocytic R21/Matrix-M and blood-stage RH5.1/Matrix-M malaria vaccines in endemic settings.Bundi, C. K. Munoz, O. Kibwana, E. Bellamy, D. Stockdale, L. Barrett, J. R. McHugh, K. Mtaka, I. Kalinga, W. Kimani, D. Nyamako, L. Keter, K. Ogwang, R. Hill, A. V. S. Bejon, P. Hamaluba, M. Silk, S. E. Minassian, A. M. Draper, S. J. Olotu, A. I. Kapulu, M. C. Ewer, K. J. Nielsen, C. M.
Front Immunol, (2026). 17:1743327

Controlled human malaria infection studies: insights into recent advances and key immunological and ethical implementation lessons.Ogwang, R. Adan, M. Bejon, P. Kapulu, M. C.
Front Immunol, (2025). 16:1672945

R21/Matrix-M malaria vaccine drives diverse immune responses in pre-exposed adults: insights from a phase IIb controlled human malaria infection trial.Kibwana, E. Bundi, C. Kimani, D. Nyamako, L. Keter, K. Mutiso, A. Ogwang, R. Bellamy, D. Rapi, K. Bajer, A. Provstgaard-Morys, S. Stockdale, L. Munoz, O. Datoo, M. S. Lawrie, A. Ramos-Lopez, F. Roberts, R. Hamaluba, M. Hill, A. V. S. Bejon, P. Ewer, K. J. Kapulu, M.
Front Immunol, (2025). 16:1620365

Vaccine-induced responses to R21/Matrix-M - an analysis of samples from a phase 1b age de-escalation, dose-escalation trial.Bundi, C. Bellamy, D. Kibwana, E. Nyamako, L. Ogwang, R. Keter, K. Kimani, D. Salman, A. M. Provstgaard-Morys, S. Stockdale, L. Hill, A. V. S. Bejon, P. Olotu, A. Hamaluba, M. Ewer, K. J. Kapulu, M. C.
Front Immunol, (2025). 16:1620366

Bi-isotype immunoglobulins enhance antibody-mediated neutrophil activity against Plasmodium falciparum parasites.Ogwang, R. Murugu, L. Nkumama, I. N. Nyamako, L. Kai, O. Mwai, K. Murungi, L. Idro, R. Bejon, P. Tuju, J. Kinyanjui, S. M. Osier, F. H. A.
Front Immunol, (2024). 15:1360220

Age-dependent acquisition of IgG antibodies to Shigella serotypes-a retrospective analysis of seroprevalence in Kenyan children with implications for infant vaccination.Kapulu, M. C. Muthumbi, E. Otieno, E. Rossi, O. Ferruzzi, P. Necchi, F. Acquaviva, A. Martin, L. B. Orindi, B. Mwai, K. Kibet, H. Mwanzu, A. Bigogo, G. M. Verani, J. R. Mbae, C. Nyundo, C. Agoti, C. N. Nakakana, U. N. Conti, V. Bejon, P. Kariuki, S. Scott, J. A. G. Micoli, F. Podda, A.
Front Immunol, (2024). 15:1340425

Complement-mediated serum bactericidal activity of antibodies elicited by the Shigella sonnei GMMA vaccine in adults from a shigellosis-endemic country: Exploratory analysis of a Phase 2a randomized study.Kapulu, M. C. Nakakana, U. Scire, A. S. Sarakinou, E. Conti, V. Rossi, O. Acquaviva, A. Necchi, F. Obiero, C. W. Martin, L. B. Bejon, P. Njuguna, P. Micoli, F. Podda, A.
Front Immunol, (2022). 13:971866

Breadth of Antibodies to Plasmodium falciparum Variant Surface Antigens Is Associated With Immunity in a Controlled Human Malaria Infection Study.Kimingi, H. W. Kinyua, A. W. Achieng, N. A. Wambui, K. M. Mwangi, S. Nguti, R. Kivisi, C. A. Jensen, A. T. R. Bejon, P. Kapulu, M. C. Abdi, A. I. Kinyanjui, S. M. Chmi-Sika Study Team
Front Immunol, (2022). 13:894770

Plasmodium falciparum-Specific Memory B-Cell and Antibody Responses Are Associated With Immunity in Children Living in an Endemic Area of Kenya.Jahnmatz, P. Nyabundi, D. Sundling, C. Widman, L. Mwacharo, J. Musyoki, J. Otieno, E. Ahlborg, N. Bejon, P. Ndungu, F. M. Farnert, A.
Front Immunol, (2022). 13:799306

Antibody Responses to Crude Gametocyte Extract Predict Plasmodium falciparum Gametocyte Carriage in Kenya.Omondi, B. R. Muthui, M. K. Muasya, W. I. Orindi, B. Mwakubambanya, R. S. Bousema, T. Drakeley, C. Marsh, K. Bejon, P. Kapulu, M. C.
Front Immunol, (2020). 11:609474

Corrigendum: Immune Responses to Gametocyte Antigens in a Malaria Endemic Population-The African falciparum Context: A Systematic Review and Meta-Analysis.Muthui, M. K. Kamau, A. Bousema, T. Blagborough, A. M. Bejon, P. Kapulu, M. C.
Front Immunol, (2020). 11:389

Immune Responses to Gametocyte Antigens in a Malaria Endemic Population-The African falciparum Context: A Systematic Review and Meta-Analysis.Muthui, M. K. Kamau, A. Bousema, T. Blagborough, A. M. Bejon, P. Kapulu, M. C.
Front Immunol, (2019). 10:2480

KILchip v1.0: A Novel Plasmodium falciparum Merozoite Protein Microarray to Facilitate Malaria Vaccine Candidate Prioritization.Kamuyu, G. Tuju, J. Kimathi, R. Mwai, K. Mburu, J. Kibinge, N. Chong Kwan, M. Hawkings, S. Yaa, R. Chepsat, E. Njunge, J. M. Chege, T. Guleid, F. Rosenkranz, M. Kariuki, C. K. Frank, R. Kinyanjui, S. M. Murungi, L. M. Bejon, P. Farnert, A. Tetteh, K. K. A. Beeson, J. G. Conway, D. J. Marsh, K. Rayner, J. C. Osier, F. H. A.
Front Immunol, (2018). 9:2866

A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against Shigella sonnei Administered Intramuscularly to Adults from a Shigellosis-Endemic Country.Obiero, C. W. Ndiaye, A. G. W. Scire, A. S. Kaunyangi, B. M. Marchetti, E. Gone, A. M. Schutte, L. D. Riccucci, D. Auerbach, J. Saul, A. Martin, L. B. Bejon, P. Njuguna, P. Podda, A.
Front Immunol, (2017). 8:1884